<< Read Full Article
<< Read Full Article
Editor's note: Adam Feuerstein will pinpoint the biotech stocks with potential to take off in '09 at TheStreet.com Investment Conference on Saturday, Oct. 25.
Times are tough but not tough enough to keep a lid on the Biotech Mailbag. Kent P. asks:
"Is there any hope for Onyx Pharmaceuticals(ONXX Quote)? It has dropped to about $29 from $44 in August. Will there be any good news or quarterly reports coming down our way to erase this loss?"
Onyx started the year at $55, so the performance of the stock is even worse than Kent describes. Remember 2007? Onyx was the best-performing biotech stock of the year. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet